Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments

This publication has 51 references indexed in Scilit:

• Infectious complications of biologic treatments of rheumatoid arthritis
  Current Opinion in Rheumatology, 2003
• Treating Crohn's Disease by Inducing T Lymphocyte Apoptosis
  Annals of the New York Academy of Sciences, 2002
• Expression of inducible nitric oxide synthase and nitrotyrosineduring the evolution of experimental pulmonary tuberculosis
  Experimental and Toxicologic Pathology, 2001
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001
• Genetic Regulation of Acquired Immune Responses to Antigens ofMycobacterium tuberculosis:a Study of Twins in West Africa
  Infection and Immunity, 2001
• Immunology of Tuberculosis
  Annual Review of Immunology, 2001
• Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology
  Immunology, 2001
• Interleukin-7 or Interleukin-15 Enhances Survival ofMycobacterium tuberculosis-Infected Mice
  Infection and Immunity, 2000
• Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria
  Immunology Today, 1998
• Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
  JAMA, 1994